Research progress in the diagnosis and treatment of intrahepatic cholangiocellular carcinoma

VernacularTitle:肝内胆管细胞癌诊疗研究进展
Author: Yingtian SHEN ¹ ; Haidong ZHU ; Li CHEN ; Binyan ZHONG ; Gaojun TENG
Author Information

1. 210009,南京东南大学医学院
Keywords: intrahepatic cholangiocellular carcinoma; diagnosis; surgical resection; local treatment
From: Journal of Interventional Radiology 2018;27(3):285-289
CountryChina
Language:Chinese
Abstract: Intrahepatic cholangiocellular carcinoma (ICC) is a primary tumor originating from the epithelial cells of bile duct. In recent years, incidence of ICC in the world is on the rise, and it has become the second common malignant tumors of the liver, with its incidence being next only to hepatocellular carcinoma (HCC). The onset of ICC is insidious, its clinical manifestations are lack of specificity, most of the patients are already in the advanced stage when the diagnosis is confirmed, thus, affecting the treatment and prognosis. Therefore, early diagnosis and treatment is essential. The radical treatment plan is mainly surgical excision, and other treatment options include systemic chemotherapy, local ablation, transcatheter arterial chemoembolization (TACE), selective intraarterial radiotherapy with yttrium-90 microspheres (SIRT-90Y), 125I seed implantation, etc. This article aims to make a comprehensive introduction about the recent advances in the diagnosis and treatment of ICC. (J Intervent Radiol, 2018, 27:285-289)